{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,27]],"date-time":"2026-08-27T03:21:58Z","timestamp":1787800918234,"version":"build-2784847793"},"reference-count":21,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"34","license":[{"start":{"date-parts":[[2021,8,27]],"date-time":"2021-08-27T00:00:00Z","timestamp":1630022400000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"abstract":"<jats:sec>\n            <jats:title>Abstract<\/jats:title>\n            <jats:p>Non-alcoholic fatty liver disease (NAFLD) is a risk factor for cardiac mortality. Pericoronary adipose tissue (PCAT) attenuation, expressed by the fat attenuation index on coronary computed tomography angiography, reflects pericoronary inflammation. We aimed to investigate the association between PCAT attenuation and NAFLD.<\/jats:p>\n            <jats:p>This is a single-center cohort study comprising of patients who underwent coronary computed tomography angiography for suspected stable coronary artery disease between January and December 2020. Patient characteristics and coronary computed tomography angiography findings were analyzed between patients with NAFLD (n\u200a=\u200a78) and a propensity score-matched cohort of patients without NAFLD (n\u200a=\u200a78). PCAT attenuation was assessed in Hounsfield units (HU) of proximal 40-mm segments of the left anterior descending artery (LAD) and right coronary artery.<\/jats:p>\n            <jats:p>The mean PCAT attenuation in LAD and right coronary artery were significantly higher in patients with NAFLD than those without NAFLD. When patients were divided into 2 groups using the median LAD-PCAT attenuation of \u221272.5 HU, the high PCAT attenuation group had more males (82% vs 67%, <jats:italic toggle=\"yes\">P<\/jats:italic>\u200a=\u200a.028) and NAFLD patients (63% vs 37%, <jats:italic toggle=\"yes\">P<\/jats:italic>\u200a=\u200a.001) compared to the low PCAT attenuation group. No differences in age, body mass index, conventional cardiovascular risk factors, or the presence of high-risk plaque were observed between the 2 groups. In the multivariate logistic analysis, NAFLD was independently associated with high PCAT attenuation (odds ratio 2.912, 95% confidence interval 1.386 to 6.118, <jats:italic toggle=\"yes\">P<\/jats:italic>\u200a=\u200a.005).<\/jats:p>\n            <jats:p>NAFLD is associated with high PCAT attenuation on coronary computed tomography angiography. This finding suggests that pericoronary inflammation is involved in the increased cardiac mortality in NAFLD patients.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1097\/md.0000000000027043","type":"journal-article","created":{"date-parts":[[2021,8,27]],"date-time":"2021-08-27T17:05:39Z","timestamp":1630083939000},"page":"e27043","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":11,"title":["Association between higher pericoronary adipose tissue attenuation measured by coronary computed tomography angiography and nonalcoholic fatty liver disease"],"prefix":"10.1097","volume":"100","author":[{"given":"Keishi","family":"Ichikawa","sequence":"first","affiliation":[{"name":"Department of Cardiovascular Medicine, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, Okayama, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9039-3439","authenticated-orcid":false,"given":"Toru","family":"Miyoshi","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular Medicine, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, Okayama, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kazuhiro","family":"Osawa","sequence":"additional","affiliation":[{"name":"Department of General Internal Medicine 3, Kawasaki Medical School General Medical Center, Okayama, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takashi","family":"Miki","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular Medicine, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, Okayama, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yusuke","family":"Morimitsu","sequence":"additional","affiliation":[{"name":"Department of Medical technology, Okayama University Hospital, Okayama, Japan."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Noriaki","family":"Akagi","sequence":"additional","affiliation":[{"name":"Department of Medical technology, Okayama University Hospital, Okayama, Japan."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mitsutaka","family":"Nakashima","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular Medicine, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, Okayama, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroshi","family":"Ito","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular Medicine, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, Okayama, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2021,8,27]]},"reference":[{"key":"R1-20250504","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1016\/j.atherosclerosis.2013.07.052","article-title":"A systematic review: burden and severity of subclinical cardiovascular disease among those with nonalcoholic fatty liver; should we care?","volume":"230","author":"Oni","year":"2013","journal-title":"Atherosclerosis"},{"key":"R2-20250504","doi-asserted-by":"crossref","first-page":"1628","DOI":"10.1016\/j.jcmg.2020.01.022","article-title":"Prognostic value of coronary computed tomographic angiography in patients with nonalcoholic fatty liver disease","volume":"13","author":"Ichikawa","year":"2020","journal-title":"JACC Cardiovasc Imaging"},{"key":"R3-20250504","doi-asserted-by":"crossref","first-page":"1341","DOI":"10.1056\/NEJMra0912063","article-title":"Risk of cardiovascular disease in patients with nonalcoholic fatty liver disease","volume":"363","author":"Targher","year":"2010","journal-title":"N Engl J Med"},{"key":"R4-20250504","doi-asserted-by":"crossref","first-page":"e0131138","DOI":"10.1371\/journal.pone.0131138","article-title":"Nonalcoholic hepatic steatosis is a strong predictor of high-risk coronary-artery plaques as determined by multidetector CT","volume":"10","author":"Osawa","year":"2015","journal-title":"PLoS One"},{"key":"R5-20250504","doi-asserted-by":"crossref","first-page":"1157","DOI":"10.1016\/j.cgh.2018.11.037","article-title":"Liver fat is associated with markers of inflammation and oxidative stress in analysis of data from the framingham heart study","volume":"17","author":"Fricker","year":"2019","journal-title":"Clin Gastroenterol Hepatol"},{"key":"R6-20250504","doi-asserted-by":"crossref","first-page":"1000344","DOI":"10.4172\/2155-9880.1000344","article-title":"Association between inflammatory markers and liver fat: the multi-ethnic study of atherosclerosis","volume":"5","author":"Hamirani","year":"2014","journal-title":"J Clin Exp Cardiolog"},{"key":"R7-20250504","doi-asserted-by":"crossref","first-page":"E121","DOI":"10.1093\/eurheartj\/suaa076","article-title":"Coronary inflammation: why searching, how to identify and treat it","volume":"22","author":"Prati","year":"2020","journal-title":"Eur Heart J Suppl"},{"key":"R8-20250504","doi-asserted-by":"crossref","first-page":"eaal2658","DOI":"10.1126\/scitranslmed.aal2658","article-title":"Detecting human coronary inflammation by imaging perivascular fat","volume":"9","author":"Antonopoulos","year":"2017","journal-title":"Sci Transl Med"},{"key":"R9-20250504","doi-asserted-by":"crossref","first-page":"636","DOI":"10.1093\/ehjci\/jez013","article-title":"Relationship between changes in pericoronary adipose tissue attenuation and coronary plaque burden quantified from coronary computed tomography angiography","volume":"20","author":"Goeller","year":"2019","journal-title":"Eur Heart J Cardiovasc Imaging"},{"key":"R10-20250504","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1016\/S0140-6736(18)31114-0","article-title":"Non-invasive detection of coronary inflammation using computed tomography and prediction of residual cardiovascular risk (the CRISP CT study): a post-hoc analysis of prospective outcome data","volume":"392","author":"Oikonomou","year":"2018","journal-title":"Lancet"},{"key":"R11-20250504","doi-asserted-by":"crossref","first-page":"08","DOI":"10.1186\/s12933-020-01192-4","article-title":"Prognostic value of non-alcoholic fatty liver disease for predicting cardiovascular events in patients with diabetes mellitus with suspected coronary artery disease: a prospective cohort study","volume":"20","author":"Ichikawa","year":"2021","journal-title":"Cardiovasc Diabetol"},{"key":"R12-20250504","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/j.ijcard.2020.09.060","article-title":"Higher oxidized high-density lipoprotein to apolipoprotein A-I ratio is associated with high-risk coronary plaque characteristics determined by CT angiography","volume":"324","author":"Suruga","year":"2021","journal-title":"Int J Cardiol"},{"key":"R13-20250504","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/j.jcct.2020.11.002","article-title":"Society of cardiovascular computed tomography \/North American Society of Cardiovascular Imaging - Expert Consensus Document on Coronary CT Imaging of Atherosclerotic Plaque","volume":"15","author":"Shaw","year":"2021","journal-title":"J Cardiovasc Comput Tomogr"},{"key":"R14-20250504","doi-asserted-by":"crossref","first-page":"748","DOI":"10.1093\/eurheartj\/ehz474","article-title":"Imaging residual inflammatory cardiovascular risk","volume":"41","author":"Antoniades","year":"2020","journal-title":"Eur Heart J"},{"key":"R15-20250504","doi-asserted-by":"crossref","first-page":"e016202","DOI":"10.1161\/JAHA.120.016202","article-title":"Determinants of pericoronary adipose tissue attenuation on computed tomography angiography in coronary artery disease","volume":"9","author":"Sugiyama","year":"2020","journal-title":"J Am Heart Assoc"},{"key":"R16-20250504","doi-asserted-by":"crossref","first-page":"948","DOI":"10.1016\/j.jacc.2018.11.050","article-title":"Nonalcoholic fatty liver disease and the heart: JACC state-of-the-art review","volume":"73","author":"Stahl","year":"2019","journal-title":"J Am Coll Cardiol"},{"key":"R17-20250504","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1016\/j.jhep.2016.04.005","article-title":"Non-alcoholic fatty liver disease and cardiovascular risk: Pathophysiological mechanisms and implications","volume":"65","author":"Francque","year":"2016","journal-title":"J Hepatol"},{"key":"R18-20250504","doi-asserted-by":"crossref","first-page":"2511","DOI":"10.1016\/j.jacc.2018.02.079","article-title":"Coronary atherosclerotic precursors of acute coronary syndromes","volume":"71","author":"Chang","year":"2018","journal-title":"J Am Coll Cardiol"},{"key":"R19-20250504","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1016\/j.ijcard.2020.06.008","article-title":"Serial change of perivascular fat attenuation index after statin treatment: Insights from a coronary CT angiography follow-up study","volume":"319","author":"Dai","year":"2020","journal-title":"Int J Cardiol"},{"key":"R20-20250504","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/j.atherosclerosis.2020.10.006","article-title":"High levels of eicosapentaenoic acid are associated with lower pericoronary adipose tissue attenuation as measured by coronary CTA","volume":"316","author":"Bittner","year":"2021","journal-title":"Atherosclerosis"},{"key":"R21-20250504","doi-asserted-by":"crossref","first-page":"3925","DOI":"10.1093\/eurheartj\/ehaa652","article-title":"Effect of icosapent ethyl on progression of coronary atherosclerosis in patients with elevated triglycerides on statin therapy: final results of the EVAPORATE trial","volume":"41","author":"Budoff","year":"2020","journal-title":"Eur Heart J"}],"container-title":["Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000027043","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,4]],"date-time":"2025-05-04T05:37:39Z","timestamp":1746337059000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000027043"}},"subtitle":["A matched case-control study"],"short-title":[],"issued":{"date-parts":[[2021,8,27]]},"references-count":21,"journal-issue":{"issue":"34","published-online":{"date-parts":[[2021]]}},"URL":"https:\/\/doi.org\/10.1097\/md.0000000000027043","relation":{},"ISSN":["0025-7974","1536-5964"],"issn-type":[{"value":"0025-7974","type":"print"},{"value":"1536-5964","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,8,27]]},"assertion":[{"value":"2021-05-12","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2021-08-11","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}